Diagnostic criteria for neurofibromatosis type 1 (NF1) were established by a panel of experts at a National Institutes of Health (NIH) Consensus Development Conference in 1987. 1 A total of seven ...

Neurofibromatosis type 1 (NF1), a common autosomal dominant disorder affecting ≈1/3500 individuals worldwide, has variable expressivity. Clinical manifestations include café-au-lait macules, ...

Lovastatin, a drug used to lower cholesterol and help prevent cardiovascular disease, has been shown to improve bone healing in an animal model of neurofibromatosis type 1 (NF1). The research, ...

Neurofibromatosis is an incurable genetic disorder of the nervous system. It mainly affects the development of nerve cell tissues. Tumors known as neurofibromas develop on the nerves, and these can ...